<p>➀ A new LOEWE research project at TU Darmstadt, funded with €4.3 million, aims to develop a portable bedside sensor system for real-time drug monitoring in pediatric cancer patients;</p><p>➁ The system will enable personalized dosage adjustments by analyzing drug concentrations in blood samples on-site, replacing time-consuming lab processes and improving treatment efficacy and safety;</p><p>➂ Combining expertise in biosensors, AI-driven data analysis, and clinical oncology, the interdisciplinary project could pioneer intelligent, adaptive medical technology and strengthen Hessian research networks.</p>
Related Articles
- Smart and Compact Sensors with Edge-AI6 months ago
- Smart Implants with Miniaturized Motors Find Their Place in Bone Screws at Hannover Messe7 months ago
- 5G in the Operating Room: Technological Advancements Unlock Opportunities for Hospitals11 months ago
- Cisco Silicon One P200 and Cisco 8223 for 51.2T Scale Across Networking3 days ago
- Picture of the Day: LightMatter’s Passage M1000 3D photonic superchip4 days ago
- AI adoption far outpaces that of the early Internet — report sheds light on worldwide AI penetration and usage patterns5 days ago
- RISC-V set to announce 25% market penetration — open-standard ISA is ahead of schedule, securing fast-growing silicon footprint5 days ago
- Bochum University of Applied Sciences Strengthens Partnerships in Kenya5 days ago
- AI-Driven Cyber Defense Framework5 days ago
- AI company goes bust5 days ago